UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.679
EU - Europa 5.965
AS - Asia 5.013
SA - Sud America 708
OC - Oceania 114
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 16
Totale 28.527
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.552
SG - Singapore 1.910
CN - Cina 1.610
UA - Ucraina 1.408
IT - Italia 1.373
RU - Federazione Russa 900
BR - Brasile 649
DE - Germania 646
IE - Irlanda 597
VN - Vietnam 465
TR - Turchia 378
KR - Corea 361
SE - Svezia 312
FI - Finlandia 276
EE - Estonia 146
HK - Hong Kong 123
GB - Regno Unito 104
CA - Canada 89
AU - Australia 60
IN - India 60
NZ - Nuova Zelanda 54
NL - Olanda 40
AT - Austria 37
FR - Francia 36
CZ - Repubblica Ceca 27
MX - Messico 20
AR - Argentina 18
EU - Europa 16
IQ - Iraq 14
BD - Bangladesh 11
PK - Pakistan 11
EC - Ecuador 10
IL - Israele 10
UZ - Uzbekistan 10
JP - Giappone 9
PL - Polonia 9
BE - Belgio 8
MA - Marocco 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
VE - Venezuela 7
CL - Cile 6
CO - Colombia 6
ES - Italia 6
GR - Grecia 5
KE - Kenya 5
CH - Svizzera 4
CR - Costa Rica 4
DK - Danimarca 4
IR - Iran 4
JM - Giamaica 4
LU - Lussemburgo 4
NP - Nepal 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
TW - Taiwan 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
JO - Giordania 3
PA - Panama 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
ID - Indonesia 2
KG - Kirghizistan 2
MK - Macedonia 2
NO - Norvegia 2
PE - Perù 2
RS - Serbia 2
SV - El Salvador 2
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 28.527
Salva come PNG Salva come JPEG
Città #
Ann Arbor 4.156
Wilmington 2.250
Jacksonville 1.728
Princeton 1.634
Chandler 1.535
Houston 728
Singapore 645
Woodbridge 616
Dublin 569
Dong Ket 459
Ashburn 402
Nanjing 399
Andover 368
Izmir 364
Moscow 310
Boardman 297
Beijing 276
Pellezzano 264
Düsseldorf 216
Mestre 203
Naples 147
Tallinn 146
Norwalk 143
Shenyang 134
Fairfield 131
Hebei 121
Salerno 120
Hong Kong 117
Changsha 110
Nanchang 108
Dearborn 107
Jiaxing 85
Redwood City 60
Rome 59
Tianjin 56
San Diego 49
Los Angeles 48
Pune 46
São Paulo 44
Dallas 42
Nuremberg 42
West Jordan 35
Milan 34
The Dalles 33
Cambridge 31
Jinan 29
Washington 29
Sydney 28
Ottawa 26
Auckland 25
Seattle 25
Guangzhou 21
Amsterdam 20
Belo Horizonte 20
Fort Worth 20
Lappeenranta 20
Rio de Janeiro 19
Springfield 19
Casoria 18
Venezia 18
Brasília 17
Shanghai 17
Brno 15
Lecce 14
Council Bluffs 13
Hangzhou 13
Bologna 12
Melbourne 12
Prineville 12
Curitiba 11
Vienna 11
Campinas 10
Dormagen 10
Fuzhou 10
Kunming 10
Napoli 10
Pompei 10
Wuhan 10
Frankfurt am Main 9
Padova 9
Santa Clara 9
São Bernardo do Campo 9
Taizhou 9
Brisbane 8
Falls Church 8
Munich 8
New York 8
Perugia 8
Porto Alegre 8
Ribeirão Preto 8
Tashkent 8
Zhengzhou 8
Baghdad 7
Carapicuíba 7
Christchurch 7
Montreal 7
San Francisco 7
Wellington 7
Assago 6
Birmingham 6
Totale 20.192
Salva come PNG Salva come JPEG
Nome #
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 163
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 160
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 150
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 142
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 139
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 134
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 129
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 127
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 126
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 125
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 122
The natural history of multiple system atrophy: A prospective European cohort study 119
The PRIAMO study: background, methods and recruitment. Apr;29(2):61-5. .PMID: 18483702 117
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 117
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 114
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 113
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: A randomised, placebo-controlled trial 111
Normative data for the Montreal Cognitive Assessment in an Italian population sample 111
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 110
Increased bilirubin levels in de novo Parkinson's disease 109
Long-term safety of rivastigmine in parkinson disease dementia: An open-label, randomized study 108
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 107
Affective theory of mind in patients with Parkinson's disease: comment 106
The "gender factor" in wearing-off among patients with parkinson's disease: A post hoc analysis of DEEP study 106
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 105
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. 104
Sindromi parkinsoniane 102
The alpha-synuclein gene in multiple system atrophy 100
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 99
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 99
The accuracy of the arginine growth hormone test in parkinsonism. 98
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 97
D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine. 96
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 96
Aiming for study comparability in Parkinson's disease: Proposal for a modular set of biomarker assessments to be used in longitudinal studies 95
Gender and non motor fluctuations in Parkinson's disease: A prospective study 95
Malabsorption is uncommon in restless legs syndrome. 94
Clinical variables associated with treatment changes in Parkinson’s disease: results from the longitudinal phase of the REASON study 94
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 93
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 93
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 93
Diagnosis and management of Parkinson's disease dementia. Oct;62(10):1581-7. Review.PMID: 18822028 92
Apathy and related executive syndromes in dementia associated with Parkinson's disease and in Alzheimer's disease 92
Prophylaxis of migraine attacks with a calcium-channel blocker: flunarizine versus methysergide 91
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 91
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 91
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 91
Dopamine mediated responses in 6-OH-DA lesioned rats involve changes of the signal transduction. 90
Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease. 90
Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression? 90
Pisa syndrome in Parkinson disease: An observational multicenter Italian study 90
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 90
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients. Aug 15;23(11):1532-40.PMID: 18581467 89
On the relationship between side of onset and cognition in Parkinson disease 89
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 89
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 89
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. 88
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 88
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 88
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study. 87
Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study 87
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 87
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 86
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Sep;132(Pt 9):2350-5. PMID: 19584099 86
Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors. 86
Nitric oxide-haemoglobin interaction: a new biochemical hypothesis for signal changes in fMRI. 86
Pramipexole in patients with early Parkinson's disease (PROUD): A randomised delayed-start trial 86
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family 86
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 86
The relevance of gender in Parkinson's disease: a review 85
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 85
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 85
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 85
Quitting smoking: An early non-motor feature of Parkinson's disease? 84
Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptors. 84
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 84
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 84
Early MRI findings in acquired hepatocerebral degeneration. 83
D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models andparkinsonian patients. 83
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale 83
Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson's disease 83
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease-Report of the JPND Working Group BioLoC-PD 83
Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards 83
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 83
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. 82
Efficacy and safety of extended- versus immediate-release pramipexole in Japanese patients with advanced and (L)-dopa-undertreated Parkinson disease: a double-blind, randomized trial. 82
Plasma prolactin response to sodium valproate in epileptic patients 82
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease 82
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 82
Apathy in Parkinson's disease: Diagnosis, neuropsychological correlates, pathophysiology and treatment 82
Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 82
Perspectives on recent advances in the understanding and treatment of Parkinson's disease. Oct;16(10):1090-9. Review.PMID: 19723294 81
Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine. 81
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 81
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 81
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 81
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 81
Attenuation of D-1 antagonist-induced D-1 receptor upregulation by concomitant D-2 receptor blockade. 80
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 80
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 80
Totale 9.656
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020593 0 0 0 0 0 0 0 0 0 0 547 46
2020/20212.645 24 248 270 10 363 136 344 19 305 22 341 563
2021/20222.615 14 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20254.864 260 60 145 369 216 669 731 686 911 692 125 0
Totale 29.594